标题
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
作者
关键词
-
出版物
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 51, Issue 5, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-05-09
DOI
10.1038/s12276-019-0250-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale
- (2018) Sylvain Lehmann et al. Frontiers in Aging Neuroscience
- Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays
- (2018) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer’s Disease: A Pilot Study
- (2018) Ivan Koychev et al. JOURNAL OF ALZHEIMERS DISEASE
- A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
- (2018) Hedieh Shahpasand-Kroner et al. Alzheimers Research & Therapy
- Diagnostic Biomarkers of Alzheimer’s Disease as Identified in Saliva using 1H NMR-Based Metabolomics
- (2017) Ali Yilmaz et al. JOURNAL OF ALZHEIMERS DISEASE
- Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease
- (2017) T M Shah et al. MOLECULAR PSYCHIATRY
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls
- (2016) João Figueira et al. Molecular BioSystems
- CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
- (2016) Shorena Janelidze et al. Annals of Clinical and Translational Neurology
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Melanopsin retinal ganglion cell loss in Alzheimer disease
- (2015) Chiara La Morgia et al. ANNALS OF NEUROLOGY
- Tau Protein Detection in Anosmic Alzheimer’s Disease Patient’s Nasal Secretions
- (2015) G. C. Passali et al. Chemosensory Perception
- Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
- (2015) Katarzyna Adamczuk et al. Alzheimers Research & Therapy
- Detection of Amyloid β Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer’s Disease
- (2014) Charles Kerbage et al. American Journal of Alzheimers Disease and Other Dementias
- Novel plasma biomarker surrogating cerebral amyloid deposition
- (2014) Naoki KANEKO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
- (2013) C. L. Masters et al. Cold Spring Harbor Perspectives in Medicine
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- The Neuropsychological Profile of Alzheimer Disease
- (2013) S. Weintraub et al. Cold Spring Harbor Perspectives in Medicine
- Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
- (2012) Mirko Bibl et al. JOURNAL OF NEURAL TRANSMISSION
- Alzheimers Disease in the Retina: Imaging Retinal Aß Plaques for Early Diagnosis and Therapy Assessment
- (2012) Yosef Koronyo et al. Neurodegenerative Diseases
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- A Blood-Based Algorithm for the Detection of Alzheimer’s Disease
- (2011) Sid E. O’Bryant et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Epidemiology of Alzheimer disease
- (2011) Christiane Reitz et al. Nature Reviews Neurology
- CSF tau markers are correlated with hippocampal volume in Alzheimer's disease
- (2011) Leonardo C. de Souza et al. NEUROBIOLOGY OF AGING
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
- (2010) Laurel A. Beckett et al. Alzheimers & Dementia
- Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults
- (2010) Erik Stomrud et al. ARCHIVES OF NEUROLOGY
- Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study
- (2010) Felix Bermejo-Pareja et al. BMC Neurology
- Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model
- (2010) Maya Koronyo-Hamaoui et al. NEUROIMAGE
- Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome
- (2010) Juliet A. Moncaster et al. PLoS One
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
- (2009) Timo Grimmer et al. BIOLOGICAL PSYCHIATRY
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
- (2009) Clifford R. Jack et al. BRAIN
- Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease
- (2009) R. Michael Dutescu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
- (2009) Volker Welge et al. JOURNAL OF NEURAL TRANSMISSION
- Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding
- (2009) N. Tolboom et al. JOURNAL OF NUCLEAR MEDICINE
- Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men
- (2008) Johan Sundelöf et al. ARCHIVES OF NEUROLOGY
- Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2008) Oskar Hansson et al. NEUROBIOLOGY OF AGING
- Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
- (2007) Christin Andersson et al. NEUROBIOLOGY OF AGING
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started